The Association of Innovative Pharmaceutical Industries (AIFP) brings together 35 companies that can develop and bring to market new, more effective and safer medicines. Most AIFP member companies come from countries that are cradles of drug research and development. In the last 30 years, these companies have developed 90% of new medicines. They now account for 70% of global pharmaceutical market turnover.
AIFP activities are built on 4 pillars:
- availability of innovative medicines for patients
- ethical conduct and transparency (including self-regulatory rules)
- contribution to society, economy
- cooperation with professionals and patients